Order Now For Fast Delivery!
This website uses cookies to enhance the user experience. Some cookies are essential for the use of the site. View our Privacy Policy and Cookie Policy for more information.
Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
17. Bup-nalox vs. Bup in Pregnancy
17. Bup-nalox vs. Bup in Pregnancy
Monday 27th February 2023
Discover buprenorphine treatments for opioid use disorder in pregnancy and more in this 'Addiction Medicine Journal Club' episode.
35 minutes
Informative
Engaging
Positive
Thought-provoking
Supportive
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
We believe that addiction is a disease that can be treated, and we want to help you stay up to date with the latest research that you can use in your addiction medicine practice.
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
70 (View all)
Do you want to link to this podcast?
Get the buttons here!Pregnancy and Opioid Use Disorder: A Closer Look at Buprenorphine Treatments
We know that there is a lot of art to this right. How's it accounted for, like who receives what drug, if they're all occurring simultaneously, since kind of severity and clinical situation?
Ever wondered how opioid treatments stack up during pregnancy? In this episode of the 'Addiction Medicine Journal Club', Dr. Sonya Del Tredici and Dr. John Keenan tackle the pressing topic of buprenorphine-naloxone versus buprenorphine alone for opioid use disorder in expectant mothers. They dive into a recent study published in the Journal of Addiction Medicine, exploring the effectiveness and safety of these treatments. But that's not all.
The hosts also delve into opioid-induced urinary retention and the intriguing legalization of psilocybin in Oregon for treating alcohol use disorder and depression. Drs. Del Tredici and Keenan don't shy away from discussing the standard of care for maternal opioid use disorder, neonatal opioid withdrawal syndrome, and the hurdles of prior authorization for buprenorphine.
They shed light on patient-centered outcomes and potential industry biases, making this episode a must-listen for anyone involved in addiction medicine or simply curious about these critical issues. Wrapping up on a hopeful note, they highlight the growing evidence supporting the safety of both medications during pregnancy. Tune in for an engaging and informative discussion that could reshape your understanding of addiction treatment during pregnancy.